- Home
- CGNT vs HUMA Comparison
CGNT vs HUMA Comparison
Compare CGNT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGNT
- HUMA
- Stock Information
- Founded
- CGNT 2020
- HUMA 2004
- Country
- CGNT Israel
- HUMA United States
- Employees
- CGNT N/A
- HUMA N/A
- Industry
- CGNT Computer Software: Prepackaged Software
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- CGNT Technology
- HUMA Health Care
- Exchange
- CGNT Nasdaq
- HUMA Nasdaq
- Market Cap
- CGNT 617.3M
- HUMA 324.0M
- IPO Year
- CGNT N/A
- HUMA N/A
- Fundamental
- Price
- CGNT $8.55
- HUMA $1.45
- Analyst Decision
- CGNT Buy
- HUMA Strong Buy
- Analyst Count
- CGNT 2
- HUMA 7
- Target Price
- CGNT $14.00
- HUMA $10.00
- AVG Volume (30 Days)
- CGNT 289.4K
- HUMA 5.0M
- Earning Date
- CGNT 12-10-2025
- HUMA 11-07-2025
- Dividend Yield
- CGNT N/A
- HUMA N/A
- EPS Growth
- CGNT N/A
- HUMA N/A
- EPS
- CGNT N/A
- HUMA N/A
- Revenue
- CGNT $376,566,000.00
- HUMA $818,000.00
- Revenue This Year
- CGNT $15.30
- HUMA N/A
- Revenue Next Year
- CGNT $11.30
- HUMA $1,468.13
- P/E Ratio
- CGNT N/A
- HUMA N/A
- Revenue Growth
- CGNT 14.04
- HUMA N/A
- 52 Week Low
- CGNT $6.45
- HUMA $1.15
- 52 Week High
- CGNT $11.66
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- CGNT 53.42
- HUMA 38.97
- Support Level
- CGNT $8.24
- HUMA $1.65
- Resistance Level
- CGNT $8.99
- HUMA $1.68
- Average True Range (ATR)
- CGNT 0.23
- HUMA 0.09
- MACD
- CGNT 0.05
- HUMA -0.03
- Stochastic Oscillator
- CGNT 62.66
- HUMA 6.32
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.